Biomerieux 69 Marcy (BMXMF) 108.8500 $BMXMF 2015-2019

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biomerieux 69 Marcy (BMXMF) 108.8500 $BMXMF

2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets
M2 - Fri Jul 10, 10:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kx789r/20152019_u_s) has announced the addition of the "2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others - A comprehensive analysis of the sequencing market by laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of the major molecular diagnosticanalyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom For more information visit http://www.researchandmarkets.com/research/kx...152019_u_s
SQNM: 2.95 (+0.11), MYGN: 34.32 (+0.82), A: 39.40 (+0.48), CPHD: 58.15 (+0.75), DHR: 86.65 (+0.91), HOLX: 38.71 (+0.75)

United States Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2014-2018
M2 - Fri Jul 10, 9:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2b5nf8/20142018_u_s) has announced the addition of the "2014-2018 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new five-country study contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis Five-year test volume and sales projections: - Infectious Diseases Forensic Testing - Cancer Paternity Testing/HLA Typing - Genetic DiseasesOthers - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of the major molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/2b...142018_u_s
LIFE: 18.36 (+3.03), MYGN: 34.32 (+0.82), A: 39.40 (+0.48), DHR: 86.65 (+0.91), SQNM: 2.95 (+0.11), CPHD: 58.15 (+0.75), HOLX: 38.71 (+0.75)

World Infectious Disease Molecular Diagnostics Market 2015-2019
M2 - Thu Jul 09, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4c7sd/20152019_world) has announced the addition of the "2015-2019 World Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Grifols - Hologic/Gen-Probe Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/c4...2019_world
MYGN: 34.32 (+0.82), A: 39.40 (+0.48), DHR: 86.65 (+0.91), SQNM: 2.95 (+0.11), CPHD: 58.15 (+0.75), HOLX: 38.71 (+0.75)

United States Infectious Disease Molecular Diagnostics Market 2015-2019 - Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
M2 - Wed Jul 08, 6:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9pjgrg/20152019_us) has announced the addition of the "2015-2019 US Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingfor infectious diseases Market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of leading infectious disease molecular diagnosticanalyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/9p...0152019_us
MYGN: 34.32 (+0.82), A: 39.40 (+0.48), CPHD: 58.15 (+0.75), DHR: 86.65 (+0.91), HOLX: 38.71 (+0.75)

World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2015-2019 - Country Forecasts, Emerging Technologies, Competitive Strategies
M2 - Tue Jul 07, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cshv2m/20152019_world) has announced the addition of the "2015-2019 World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. This new seven-country study contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/cs...2019_world
MYGN: 34.32 (+0.82), A: 39.40 (+0.48), CPHD: 58.15 (+0.75), DHR: 86.65 (+0.91), HOLX: 38.71 (+0.75)

New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape
PR Newswire Europe - Thu Jul 02, 7:03AM CDT
Research and Markets(http://www.researchandmarkets.com/research/8mfjxh/2015_new [http://www.researchandmarkets.com/research/8mfjxh/2015_new]) has announced the addition of the "2015 New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape" [http://www.researchandmarkets.com/research/8mfjxh/2015_new] report to their offering.
ABT: 49.93 (+0.74), A: 39.40 (+0.48), DGX: 71.58 (+0.74), DHR: 86.65 (+0.91)

2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape
PR Newswire Europe - Wed Jul 01, 10:46AM CDT
Research and Markets(http://www.researchandmarkets.com/research/34xqr7/2015_new [http://www.researchandmarkets.com/research/34xqr7/2015_new]) has announced the addition of the "2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape" [http://www.researchandmarkets.com/research/34xqr7/2015_new] report to their offering.
ABT: 49.93 (+0.74), A: 39.40 (+0.48), DGX: 71.58 (+0.74), DHR: 86.65 (+0.91)

Global Endocrine Testing Market 2015-2019
M2 - Wed Jun 24, 5:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3tpnbl/global_endocrine) has announced the addition of the "Global Endocrine Testing Market 2015-2019" report to their offering. The global endocrine testing market to grow at a CAGR of 4.66% over the period 2014-2019. Endocrine testing system refers to a collection of tests that involve all the glands of the body and the hormones produced by those glands. The endocrine system together with nervous system regulates and controls many internal body functions. While the endocrine system uses chemical messengers called hormones, the nervous system uses nerve impulses as a means of control. The endocrine system plays a role in reproduction, growth and sexual development, responses to injury and stress, body energy levels, bone and muscle strength, and internal balance of the body. The global endocrine testing market is witnessing a shift from conventional (manual) to semi-automated and highly automated systems. Automation allows laboratories to increase productivity and efficiently handle higher test volumes with fewer people. It is also useful in cases of critical shortage of trained technicians. In addition, automated systems offer a level of precision that cannot be achieved consistently by manual methods. For instance, the adoption of AUF in endocrine testing is increasing. AUF involves preparation of a sample of therapeutic drugs (e.g. Dilantin) and hormones (e.g., testosterone) efficiently for various diagnostic procedures using an automated system. Thus, it can replace the existing manual centrifugation/dialysis preparation step. The current separation process involves dialysis, which takes about 18 hours, while with AUF technology, centrifugation can be done within 30 minutes. According to the report, the number of people aged 60 and over will reach 2 billion people by 2050. By 2030, more than 22% of the world's population will be over 65. The elderly are more susceptible to diseases such as diabetes, hypertension, musculoskeletal and cardiovascular diseases, chronic kidney diseases, cerebral strokes, and cancer. Hence, the need for early and reliable diagnosis will boost the growth of the global endocrine testing market. Further, the report states that limited detection and complexity of immunoassays will hinder the widespread adoption of endocrine testing devices and instruments. To calculate the market size, we consider the revenue generated from the sales of the products (instruments and reagents) used in the following endocrine testing technologies: Types of Diagnostic Technologies - Clinical chemistry technologies - Immunoassay technologies - Tandem mass spectrometry - Monoclonal and polyclonal antibodies - Sensor technologies - Others The report also provides information about the following endocrine tests: - FSH - TSH - hCG - DHEAS - Progesterone - Testosterone - Insulin - Prolactin - Cortisol - Estradiol - Luteinizing Hormone Key Vendors - Abbott Diagnostics - Diascorin - Roche Diagnostics - Siemens Healthcare - Thermo Fisher Scientific Other Prominent Vendor - AdnaGen - Alere - Allele Biotechnology - Axis-Shield - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Diametra - Enzo Life Sciences - Fujirebio - ImmunoDX - Immunonodiagnostics System - InDevR - Innogenetics - Kyowa Medex - Merck Millipore - Meridian Bioscience - Meso Scale Discovery - NanoEnTek - Nova Century Scientific - Ortho-Clinical Diagnostics - Quidel - Randox - SDIX - Sysmex - Tecan - Tosoh Bioscience - Vital Diagnostics - ZEUS Scientific For more information visit http://www.researchandmarkets.com/research/3t..._endocrine
VIVO: 18.67 (+0.67), MRK: 57.95 (+0.57), DHR: 86.65 (+0.91)

The Global Syphilis Testing Market is Expected to Reach $3,650.3 Million by 2020, at a CAGR of 1.2%, from 2014 to 2020
M2 - Thu Jun 18, 9:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j4rm7z/global_syphilis) has announced the addition of the "Global Syphilis Testing Market (Types and Geography) - Global Industry Analysis, Country-Wise Market Size, Share, Growth, Company Profiles, Demand, Insights, Trends and Forecast, 2014 - 2020" report to their offering. LAMEA and Asia Pacific constitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. Higher adoption rates for technologically advanced screening tests methods, active measures from governments and private associations along with the growing awareness of syphilis infections, largely contributes to the growth of the market in these regions. Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions. Key findings of the study: - LAMEA will continue to lead the global market, closely followed by Asia Pacific, all through the analysis period - United states remains a major market in North America syphilis testing market through 2020 - Spain and Germany collectively accounts for about one fourth of the Europe syphilis testing market - China and India collectively accounts for about 89% share in the Asia Pacific syphilis testing market Companies Mentioned: - Abbott Laboratories - Affymetrix - Alere Inc. - Becton Dickinson And Company - BioMerieux - Cepheid Inc. - Danaher Corporation - DiaSorin - Hologic - Roche Diagnostics For more information visit http://www.researchandmarkets.com/research/j4...l_syphilis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ABT: 49.93 (+0.74), CPHD: 58.15 (+0.75), DHR: 86.65 (+0.91), ALR: 52.77 (+0.40), HOLX: 38.71 (+0.75)

2015 Strategies in the UK Drugs of Abuse Testing Market Report Explores Future Trends and Provides Forecasts
M2 - Wed Jun 10, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mccfc2/2015_strategies) has announced the addition of the "2015 Strategies in the UK Drugs of Abuse Testing Market" report to their offering. This new 260-page report provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP) and Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation.These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. "2015 Strategies for the UK Drugs of Abuse Testing Market" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. Companies Mentioned: - Abbott Laboratories - AdnaGen/Alere - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/mc...strategies About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ABT: 49.93 (+0.74), A: 39.40 (+0.48), DGX: 71.58 (+0.74), DHR: 86.65 (+0.91)

2015 Analysis of Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Strategic Profiles of Leading Suppliers
M2 - Wed Jun 10, 9:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kl6dp8/2015_analysis_of) has announced the addition of the "2015 Analysis of Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Strategic Profiles of Leading Suppliers" report to their offering. This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/kl...nalysis_of
DHR: 86.65 (+0.91), HOLX: 38.71 (+0.75)

Global Strategies in the Immunoprotein Diagnostic Testing Market 2015
M2 - Fri May 29, 8:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/63pfz3/2015_strategies) has announced the addition of the "2015 Strategies in the Global Immunoprotein Diagnostic Testing Market" report to their offering. This new 297-page report contains 72 tables and provides analysis of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. Companies Mentioned: - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/63...strategies
ABT: 49.93 (+0.74), DHR: 86.65 (+0.91)

2015 Strategies in European Immunoprotein Diagnostic Testing Market
M2 - Fri May 29, 5:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xd976z/2015_strategies) has announced the addition of the "2015 Strategies in European Immunoprotein Diagnostic Testing Market" report to their offering. This new 273-page report provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. Companies Mentioned: - Abbott Laboratories - AdnaGen - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio/Innogenetics - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/xd...strategies
ABT: 49.93 (+0.74), A: 39.40 (+0.48), DGX: 71.58 (+0.74), DHR: 86.65 (+0.91)

2015 Assessments of Major Blood Banking Product Suppliers
M2 - Fri May 29, 5:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gnkxxb/2015_assessments) has announced the addition of the "2015 Assessments of Major Blood Banking Product Suppliers" report to their offering. This new report provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/gn...ssessments
DHR: 86.65 (+0.91), HOLX: 38.71 (+0.75)

European Molecular Diagnostics Market 2015: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
M2 - Mon May 18, 10:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l6qmwp/2015_european) has announced the addition of the "2015 European Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing" report to their offering. This new 970-page comprehensive five-country report from a is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. France IV. Germany V. Italy VI. Spain VII. U.K. VIII. Major Product Development Opportunities IX. Design Criteria for Decentralized Testing Products X. Alternative Market Penetration Strategies XI. Potential Market Entry Barriers and Risks XII. Competitive Assessments XIII. Appendix Companies Mentioned - Abbott - Affymetrix - Agilent - Applied Gene Technologies - Arca - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Innogenetics/Solvay - Kreatech - Li-Cor Biosciences - Life Technologies - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Novartis - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Tecan Group For more information visit http://www.researchandmarkets.com/research/l6...5_european
LIFE: 18.36 (+3.03), MYGN: 34.32 (+0.82), DHR: 86.65 (+0.91), SQNM: 2.95 (+0.11), CPHD: 58.15 (+0.75), NVS: 103.22 (+3.20)

Global Food Safety Testing Market Outlook 2019
M2 - Mon Dec 22, 8:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/v4kvpv/global_food) has announced the addition of the "Global Food Safety Testing Market Outlook 2019" report to their offering. The problem of food affected by several contaminants is getting increasingly relevant worldwide, raising concerns for food safety testing. In today's world, the scope, relevance, and level of food safety regulation and testing have reached a high level. The worldwide rise in cases of food contamination and increased consumer awareness has generated a lot of hype around food diagnostics, transforming it into a significant public health issue. Therefore, it has become inevitable for manufacturers to seek more advanced, comprehensive, technical, yet flexible approaches to ensure the safety of their products. In the latest research report Global Food Safety Testing Market Outlook 2019, our analysts have studied the global food safety testing market in terms of contaminants and key markets. The report covers a detailed analysis of the global food safety testing market, which has been segmented into contaminants and other key markets. The food safety testing market by contaminants (pathogen, pesticides, toxins and GMO) and by food type has been forecasted till 2019. A detailed description has also been provided for the food safety market by technology for traditional testing and rapid testing (like PCR, Chromatography and ELISA). In addition, we have provided the market forecasts of the global food safety testing market for countries such as US, China and Europe till 2019. Increasing government regulations and stringent policies, which countries across the world have formulated, have resulted in stringent food safety regulations and testing methods in these countries. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Industry Trends and Drivers 4. Global Food Safety Testing Market Outlook to 2019 5. Regulatory Environment 6. Competitive Landscape Companies Mentioned: - 3M - Agilent Technologies - BioMerieux SA - BioRad - Bureau Veritas - DuPont - Eurofins - Intertek - SGS SA - Thermo Fisher Scientific Inc For more information visit http://www.researchandmarkets.com/research/v4...lobal_food
A: 39.40 (+0.48)

2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/vf9r39/20142018_us) has announced the addition of the "2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Grifols - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/vf...0142018_us
LIFE: 18.36 (+3.03), MYGN: 34.32 (+0.82), A: 39.40 (+0.48), CPHD: 58.15 (+0.75), DHR: 86.65 (+0.91)

2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/mz6ptk/20142018_us) has announced the addition of the "2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Company Profiles - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/mz...0142018_us
LIFE: 18.36 (+3.03), MYGN: 34.32 (+0.82), A: 39.40 (+0.48), DHR: 86.65 (+0.91)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 105

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 105

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 5

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 174

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 47

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Cavalry’s I-70 Towing Bet Starts With Columbus Base

Updated Category News Views 71

A jackknifed tractor-trailer does not care about a private-equity playbook. It needs the right rig, a trained crew and somebody arriving before a blocked highway turns into an all-day mess. That unglamorous reality is exactly why Southfield Capital’s new Cavalry Fleet Services platform deserves a closer look. Commercial towing is a necessary, hard-edged local business...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 138

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 157

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Workday GO for Financials Targets the Messy Middle

Updated Category News Views 25

Spreadsheets rarely die gracefully; they get buried under approvals, reconciliations, and the frantic scavenger hunt before an audit. Workday is aiming straight at that unpleasant moment with Workday GO for Financials, announced November 18 at Workday Rising EMEA in Barcelona. The pitch is not terribly romantic, thank goodness. It is a simpler way for growing companies to...

Continue Reading

Top 5 Most Recently Viewed Articles

Kering Faces Challenges as Goldman Sachs Downgrades Rating

Updated Category News Views 108

Kering's stock price took a serious hit back in early 2024 after Goldman Sachs slapped a "sell" rating on the luxury group's shares. At the time, they were sitting at €249.50, reflecting a sharp decline of about 2.9%. Desks were buzzing over this downgrade, particularly because it pointed fingers at Gucci—a brand that's been Kering’s cash cow for years. Kering's...

Continue Reading
Treatment.com AI to Showcase Innovations at Cantech Conference

Updated Category News Views 174

Treatment.com AI, a player in healthcare tech, geared up for its big moment at the Cantech Letter Investment Conference back in 2024. The spotlight was on Dr. Essam Hamza, CEO of the firm, who was set to reveal how their advanced AI-driven solutions were set to transform patient care. You could almost hear traders buzzing about the potential impact on share prices as the...

Continue Reading
Bombardier Celebrates First Challenger 3500 Deliveries

Updated Category News Views 408

Landmark Deliveries of the Challenger 3500 Bombardier proudly announces a significant achievement with the beginning of deliveries of three state-of-the-art Challenger 3500 aircraft to Aloula Aviation. This event marks a milestone as these are the first Challenger 3500 aircraft registered in Saudi Arabia, showcasing Bombardier's dedication to enhancing global aviation....

Continue Reading
Siili Solutions Shares Repurchase Update for 2025

Updated Category News Views 167

Overview of Siili Solutions Plc's Share Repurchase Siili Solutions Plc is taking significant steps to enhance shareholder value through strategic share buybacks. Recently, they announced a share repurchase on June 26, 2025, which adds to their ongoing efforts in the market. This initiative is an essential part of their financial strategy, showing a commitment to returning...

Continue Reading
Xiaomi's YU7 SUV Surpasses Tesla Model Y in China Sales

Updated Category News Views 236

Xiaomi's YU7 SUV Emerges as a Strong Contender Xiaomi Corp. has made a significant impact in the electric vehicle sector, particularly in January when their YU7 SUV surpassed Tesla Inc.'s Model Y in sales within the Chinese market. The impressive sales figures highlight Xiaomi's growing influence in the automotive landscape. Strong Sales Performance of the YU7 During the...

Continue Reading